Startseite>>Signaling Pathways>> Cardiovascular>> Coagulation & Hemostasis>>Hirudin (54-65; non-sulfated) (trifluoroacetate salt)

Hirudin (54-65; non-sulfated) (trifluoroacetate salt) (Synonyms: H-GDFEEIPEEYLQ-OH, H-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-Gln-OH)

Katalog-Nr.GC49091

A desulfated peptide fragment of hirudin

Products are for research use only. Not for human use. We do not sell to patients.

Hirudin (54-65; non-sulfated) (trifluoroacetate salt) Chemische Struktur

Cas No.: N/A

Größe Preis Lagerbestand Menge
1 mg
49,00 $
Auf Lager
5 mg
225,00 $
Auf Lager
10 mg
398,00 $
Auf Lager
25 mg
806,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Hirudin (54-65; non-sulfated) is a desulfated peptide fragment of hirudin, an anticoagulant produced by H. medicinalis.1 It inhibits fibrin clot formation induced by isolated bovine thrombin with an IC50 value of 3.7 µM.2

1.Niehrs, C., Huttner, W.B., Carvallo, D., et al.Conversion of recombinant hirudin to the natural form by in vitro tyrosine sulfation. Differential substrate specificities of leech and bovine tyrosylprotein sulfotransferasesJ. Biol. Chem.265(16)9314-9318(1990) 2.Payne, M.H., Krstenansky, J.L., Yates, M.T., et al.Positional effects of sulfation in hirudin and hirudin PA related anticoagulant peptidesJ. Med. Chem.34(3)1184-1187(1991)

Bewertungen

Review for Hirudin (54-65; non-sulfated) (trifluoroacetate salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 13 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Hirudin (54-65; non-sulfated) (trifluoroacetate salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.